Women face significantly higher risks of depression and psychosis in the weeks following childbirth, according to a major new analysis published in the journal Molecular Psychiatry. The study, which examined data from nearly 1.8 million births in Sweden between 2003 and 2019, reveals that while mental health diagnoses tend to decrease during pregnancy, they rise sharply after delivery. Researchers from Karolinska Institutet found this pattern particularly pronounced for depression and psychosis, highlighting a critical period of vulnerability for new mothers.

The analysis shows that the risk of depression is approximately 20 percent higher during weeks five to 15 postpartum compared to the year before pregnancy. For psychosis, the risk is even more dramatic—six to seven times higher in the first five weeks after childbirth and twice as high through week 20. Unlike temporary "baby blues," postpartum psychosis is a serious condition characterized by delusions, hallucinations, mania, low mood, and confusion, though women can achieve full recovery with proper treatment.

Notably, the study also found that the risk of suicide attempts decreases after childbirth, suggesting a complex interplay of factors affecting maternal mental health. Women were less likely to be diagnosed with anxiety, stress, or substance abuse during or after pregnancy than beforehand, which researchers attribute to a combination of biological and lifestyle changes. Increased medical visits during pregnancy may also lead to earlier identification of mental health issues before they escalate.

The introduction of national guidelines for screening pregnant women for depression in Sweden in 2020 has provided opportunities for earlier detection and intervention. By comparing women who gave birth before and after the guidelines were implemented, researchers observed potential benefits of systematic screening. The findings underscore the importance of targeted mental health support during the postpartum period to address the heightened risks identified in the study.

Swedish digital asset manager Virtune has launched what it claims is Europe's most cost-efficient Sui exchange-traded product (ETP) on Euronext Paris, marking another step in the company's expansion across European markets. The Virtune Sui ETP, with the ticker VRTU, provides investors with exposure to the Sui cryptocurrency through a regulated, physically backed investment vehicle. This launch comes as Virtune continues to build its position as one of the leading issuers of regulated crypto ETPs in Europe.

The new ETP features an industry-leading 0.95% annual management fee, making it the most cost-efficient Sui ETP available to European investors. Virtune plans to further expand the product's distribution by listing it on local German exchanges, including gettex and Tradegate, to improve accessibility for German investors. The company has established itself as a trusted provider in the digital asset space, serving over 150,000 investors since its launch just over two years ago.

Security and regulatory compliance remain central to Virtune's approach, with Coinbase serving as the crypto custodian for all of the company's ETPs. The underlying crypto assets are held in cold storage, providing institutional-grade security for investors. This infrastructure supports Virtune's commitment to offering European investors secure, transparent, and regulated access to digital asset markets through traditional investment channels.

Christopher Kock, CEO of Virtune, emphasized the company's mission to make innovative digital assets more accessible to investors. "We are excited to launch the most cost-efficient Sui ETP in Europe, reinforcing our mission to make innovative digital assets more accessible to investors," Kock stated. The launch strengthens Virtune's position as it manages more than $475 million in assets across its product offerings, continuing its growth trajectory in the European digital asset management landscape.